» Articles » PMID: 21647555

Vitamin D in HIV-Infected Patients

Overview
Publisher Current Science
Date 2011 Jun 8
PMID 21647555
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Observational studies have noted very high rates of low 25(OH)D (vitamin D) levels in both the general and HIV-infected populations. In HIV-infected patients, low 25(OH)D levels are likely a combination of both traditional risk factors and HIV-specific and antiretroviral therapy-specific contributors. Because of this unique risk profile, HIV-infected persons may be at greater risk for low 25(OH)D levels and frank deficiency and/or may respond to standard repletion regimens differently than HIV-uninfected patients. Currently, the optimal repletion and maintenance dosing regimens for HIV-infected patients remain unknown, as do potential benefits of supplementation that may be unique to the HIV-infected population. This paper reviews data published on HIV infection and vitamin D health in adults over the last year.

Citing Articles

Potential Advantages of a Well-balanced Nutrition Regimen for People Living with Human Immunodeficiency Virus Type -1.

Basta D, Latinovic O, Tagaya Y, Silvestri G J AIDS HIV Treat. 2024; 6(1):11-27.

PMID: 38845818 PMC: 11155617. DOI: 10.33696/aids.6.048.


Vitamin D and Probability of Developmental Disorders among Perinatally HIV-Affected and Unaffected Ugandan Children.

Awadu J, Giordani B, Sikorskii A, Abbo C, Fenton J, Zalwango S Nutrients. 2023; 15(9).

PMID: 37432158 PMC: 10181402. DOI: 10.3390/nu15092020.


The effect of antiretroviral therapy initiation on vitamin D levels and four oral diseases among Kenyan children and adolescents living with HIV.

Seminario A, Kemoli A, Fuentes W, Wang Y, Rajanbabu P, Wamalwa D PLoS One. 2022; 17(10):e0275663.

PMID: 36227876 PMC: 9560522. DOI: 10.1371/journal.pone.0275663.


Hypovitaminosis D Is Associated with Higher Levels of Inflammatory Cytokines and with HAM/TSP in HTLV-Infected Patients.

Netto E, Silva A, Pedroso C, Brites C Viruses. 2021; 13(11).

PMID: 34835029 PMC: 8623239. DOI: 10.3390/v13112223.


Induction of Autophagy to Achieve a Human Immunodeficiency Virus Type 1 Cure.

Campbell G, Spector S Cells. 2021; 10(7).

PMID: 34359967 PMC: 8307643. DOI: 10.3390/cells10071798.


References
1.
Brown T, Xu X, John M, Singh J, Kingsley L, Palella F . Fat distribution and longitudinal anthropometric changes in HIV-infected men with and without clinical evidence of lipodystrophy and HIV-uninfected controls: a substudy of the Multicenter AIDS Cohort Study. AIDS Res Ther. 2009; 6:8. PMC: 2686733. DOI: 10.1186/1742-6405-6-8. View

2.
Mueller N, Fux C, Ledergerber B, Elzi L, Schmid P, Dang T . High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS. 2010; 24(8):1127-34. DOI: 10.1097/QAD.0b013e328337b161. View

3.
Brown T, Qaqish R . Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006; 20(17):2165-74. DOI: 10.1097/QAD.0b013e32801022eb. View

4.
Scragg R, Sowers M, Bell C . Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004; 27(12):2813-8. DOI: 10.2337/diacare.27.12.2813. View

5.
Labarga P, Barreiro P, Martin-Carbonero L, Rodriguez-Novoa S, Solera C, Medrano J . Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. AIDS. 2009; 23(6):689-96. DOI: 10.1097/QAD.0b013e3283262a64. View